Peptide Compass · Research
MOTS-c: human research, exercise findings and safety questions
MOTS-c discussions mix very different types of research. The key distinction is whether a study examines cells, animals, naturally occurring levels or an administered compound. Keeping these apart helps you interpret the headlines.
MOTS-c and exercise: what was actually studied?
Natural levels
The human exercise observation measured the body’s own MOTS-c. Participants were not shown to benefit from taking a commercial MOTS-c product.
Mouse experiments
The animal experiments studied administered MOTS-c and physical performance. Animal outcomes do not establish a human benefit or a human regimen.
Human trial records
A registered trial is a research plan and status record. A recruiting or completed label is not, by itself, a result.
What is MOTS-c?
MOTS-c is a mitochondrially encoded peptide comprising 16 amino acids. Lee and colleagues described it in 2015 in research on metabolic regulation in cell and mouse models. A peptide occurring naturally in the body does not establish the safety of an externally supplied product.
Keep three types of evidence separate
Cells and animals
The 2015 paper investigated biological mechanisms and metabolic measures in preclinical models. This supports further research, not a demonstrated treatment in humans.
Human measurements
Reynolds and colleagues reported changes in endogenous MOTS-c levels in relation to exercise in 2021. This observation does not establish what administering a MOTS-c product does in humans.
Registered interventions
A trial registry describes planned or reported investigations. A registration or a “completed” status is not a set of published results. Always check which compound was actually studied.
What do the trial registrations say?
| Record | Named compound | Reported status | Interpretation |
|---|---|---|---|
| NCT07505745 | MOTS-c | Recruiting; no results posted in the registry | The record describes a randomised study in adults with prediabetes and overweight or obesity. Registration is not evidence of efficacy or independent confirmation that the study is being conducted. |
| NCT03998514 | CB4211 | Completed; no results posted in the registry | This phase 1 record names CB4211. Its information cannot simply be transferred to products sold as MOTS-c. |
Registry status can change. “No results posted” refers to the record’s results field on the review date. It is not a claim that no other publications exist anywhere.
MOTS-c protocol: what can the evidence tell you?
Searching for “MOTS-c peptide protocol” often leads to specific regimens. A regimen from a forum, product listing or animal experiment is not a validated recommendation for humans. This page therefore provides no dosage, cycle or administration steps.
Instead, check four things: Is it the same compound? Was the research conducted in humans? Was there an appropriate control group? Are results and safety data actually published? These questions determine what a source can support.
Common questions about MOTS-c
Does the exercise research demonstrate a MOTS-c treatment?
No. Changes in an endogenous measurement and the effects of an administered compound are different questions. Animal findings cannot be directly transferred either.
Does a COA establish medical safety?
A COA can document characteristics of a submitted sample under specified test conditions. It does not replace clinical safety assessment or establish suitability for human use.
How can I recognise a useful research summary?
It identifies the original source, study design, tested compound and limitations. A finding described as “observed in mice” should not become a claim about humans when retold.
Where to go next
Sources and review date
Editorial source check: 30 October 2026. Shop information is supplied by the respective vendor. Linked laboratory reports were reviewed as documents; we did not collect or analyse the samples.
- Lee et al. (2015), Cell Metabolism
- Reynolds et al. (2021), Nature Communications
- ClinicalTrials.gov: MOTS-c, NCT07505745
- ClinicalTrials.gov: CB4211, NCT03998514
Registry recheck on 1 November 2026: NCT07505745 was listed as recruiting; NCT03998514 as completed. Neither record had posted results. Their last posted updates were 1 April 2026 and 11 May 2021 respectively. Registry entries are sponsor-submitted records, not independent verification of trial conduct.
MOTS-c safety, longevity and protocol questions
Does MOTS-c extend human lifespan?
The cited exercise study does not establish human lifespan extension. Mouse physical-capacity findings and measurements of endogenous MOTS-c in people answer different questions from a controlled human longevity trial.
What side effects are established?
The registry records cited here had no posted results when checked on 1 November 2026. That does not mean there are no publications elsewhere or that adverse effects do not occur. It means those records alone cannot establish a dependable human safety profile.
Is CB4211 the same as a MOTS-c shop product?
No. The CB4211 trial names a distinct investigational compound. Its status or findings must not be attributed to an arbitrary product sold under the MOTS-c name.
Can a study protocol become a personal regimen?
No. A research protocol applies to a defined population under specific oversight and monitoring. This page provides no doses, cycles or human-use instructions.
Created with AI assistance. This new edition has not yet received independent editorial review.